Comparison of artificial neural network and anfis for parameter estimation of a tumor model

E Nagy, M Puskás, DA Drexler - 2022 IEEE 20th Jubilee World …, 2022‏ - ieeexplore.ieee.org
Cyber-medical systems are revolutionizing medicine. Mathematical therapy optimization is
one of the main pioneering results of cyber-medical system approach. Mathematical therapy …

Tumor model parameter estimation for therapy optimization using artificial neural networks

M Puskás, DA Drexler - 2021 IEEE International Conference on …, 2021‏ - ieeexplore.ieee.org
Therapy optimization and personalization in cancer treatment requires reliable mathematical
models. A key issue in personalization is the identification of the model parameters. We …

Parameter estimation from realistic experiment scenario using artificial neural networks

M Puskás, B Gergics, A Ládi… - 2022 IEEE 16th …, 2022‏ - ieeexplore.ieee.org
One of the promising directions in future medicine is the optimization of therapies based on
mathematical and engi-neering methods, with which the treatment can be personalized. In …

Modeling of tumor growth incorporating the effect of pegylated liposomal doxorubicin

DA Drexler, T Ferenci, A Lovrics… - 2019 IEEE 23rd …, 2019‏ - ieeexplore.ieee.org
Modeling tumor growth is a fundamental step in the design of automated, optimal, patient
specific therapies. We extend our tumor growth model created to describe the effect of an …

Performance of the SAEM and FOCEI algorithms in the open‐source, nonlinear mixed effect modeling tool nlmixr

R Schoemaker, M Fidler, C Laveille… - CPT …, 2019‏ - Wiley Online Library
The free and open‐source package nlmixr implements pharmacometric nonlinear mixed
effects model parameter estimation in R. It provides a uniform language to define …

Parameter identification of a tumor model using artificial neural networks

M Puskás, DA Drexler - 2021 IEEE 19th World Symposium on …, 2021‏ - ieeexplore.ieee.org
Mathematical models of tumor growth and the effect of therapy is fundamental for
personalizing and optimizing anticancer therapies. The aim of the research is to provide a …

Clinical study design strategies to mitigate confounding effects of time‐dependent clearance on dose optimization of therapeutic antibodies

JR Proctor, H Wong - CPT: Pharmacometrics & Systems …, 2025‏ - Wiley Online Library
Time‐dependent pharmacokinetics (TDPK) is a frequent confounding factor that misleads
exposure‐response (ER) analysis of therapeutic antibodies, where a decline in clearance …

Comparison of Michaelis-Menten kinetics modeling alternatives in cancer chemotherapy modeling

DA Drexler, T Ferenci, A Lovrics… - 2019 IEEE 13th …, 2019‏ - ieeexplore.ieee.org
Model-based optimization and personalization of tumor therapies require tumor growth
models that reliably describe the effect of the drug used during the therapy. A key …

Metaheuristics for pharmacometrics

S Kim, AC Hooker, Y Shi, GHJ Kim… - CPT: Pharmacometrics …, 2021‏ - Wiley Online Library
Metaheuristics is a powerful optimization tool that is increasingly used across disciplines to
tackle general purpose optimization problems. Nature‐inspired metaheuristic algorithms is a …

Model-Informed Medical Technology Development: A simulation study to evaluate the impact of model-based clinical study design and analysis on effect size …

MM Carvalho Lima Vieira Araujo - 2024‏ - diva-portal.org
Randomisedcontrolledtrials (RCT) areconsideredthegoldstandardforassessing the efficacy
and safety of medical interventions. However, RCTs face unique challenges when applied to …